Steven Rosenberg, M.D.
National Cancer Institute (NCI) · National Cancer Institute, National Institutes of Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Steven Rosenberg, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:25 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01814046 · Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular MelanomaNational Cancer Institute (NCI) · terminated · Metastatic Ocular Melanoma, Metastatic Uveal Melanoma · principal investigator
- Ph1/Ph2NCT00924001 · Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic MelanomaNational Cancer Institute (NCI) · terminated · Melanoma, Malignant Melanoma, Melanoma, Experimental · principal investigator
- Ph1NCT00923806 · Gene Therapy Using Anti-CEA Cells to Treat Metastatic CancerNational Cancer Institute (NCI) · terminated · Metastatic Cancer · principal investigator
- Ph2NCT00923195 · Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic MelanomaNational Cancer Institute (NCI) · completed · Melanoma, Skin Cancer · principal investigator
- Ph2NCT00706992 · Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma PatientsNational Cancer Institute (NCI) · terminated · Melanoma · principal investigator
- Ph2NCT00509288 · Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered LymphocytesNational Cancer Institute (NCI) · completed · Melanoma, Skin Cancer · principal investigator
- Ph2NCT00001832 · Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic MelanomaNational Cancer Institute (NCI) · completed · Melanoma, Neoplasm Metastasis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.